MC

Muniraju Chikkaarasaiah

Active Director Director DIN 10810066
DIN 10810066 First appointment Oct 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Muniraju Chikkaarasaiah

Data last updated:

Muniraju Chikkaarasaiah is a Director at Nuceutics Pharma Private Limited (since 2024). Nuceutics Pharma Private Limited reported revenue of ₹33.4 Lakh (FY 2025).

DIN 10810066
Primary Designation Director
First Appointment 16 Oct 2024
Oldest Company Age 2 yrs
Largest company Nuceutics Pharma Private Limited · ₹33.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nuceutics Pharma Private Limited U47721KA2024PTC193994
Director16 Oct 20242024₹33.4 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Nuceutics Pharma Private Limited
Premium access

Shareholding and investment profile for Muniraju Chikkaarasaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muniraju Chikkaarasaiah

Muniraju Chikkaarasaiah currently holds 1 directorship: Nuceutics Pharma Private Limited (Director, since 16 Oct 2024, revenue ₹33.4 Lakh (FY 2025)).

Muniraju Chikkaarasaiah was first appointed on 16 Oct 2024 as Director at Nuceutics Pharma Private Limited.

The current boards of Muniraju Chikkaarasaiah's companies include Madhu Sudhan Honnasandra Narasingaiah (Nuceutics Pharma Private Limited), Naveen Arerangaiaha Chinnahalli (Nuceutics Pharma Private Limited), Vasu Gunguramele Thopegowda (Nuceutics Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available